Dr Agarwal's Eye Hospital Ltd

₹ 1,235 -2.01%
07 Dec - close price
About

Dr Agarwal's Eye Hospital Ltd is a leading chain of eye hospitals with predominant presence in Tamil Nadu.[1]

Key Points

Revenue Breakup
Presently, sale of services i.e. income from surgeries, consultation, treatments & consultation accounts for ~74% revenues and sale of products i.e. optical, pharmaceuticals, contact lens & accessories, etc. accounts for ~26% of revenues of the company.[1]

  • Market Cap 580 Cr.
  • Current Price 1,235
  • High / Low 1,580 / 545
  • Stock P/E 17.5
  • Book Value 201
  • Dividend Yield 0.24 %
  • ROCE 20.0 %
  • ROE 36.0 %
  • Face Value 10.0

Pros

  • Company is expected to give good quarter
  • Company has delivered good profit growth of 25.8% CAGR over last 5 years

Cons

  • The company has delivered a poor sales growth of 6.26% over past five years.
  • Company might be capitalizing the interest cost
  • Promoters have pledged 59.8% of their holding.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
45.54 43.58 40.31 15.02 30.34 42.74 51.71 30.87 58.20 56.48 55.66 66.39 68.75
33.23 33.63 30.00 19.25 24.26 30.07 35.86 25.69 38.89 39.65 39.31 46.60 50.11
Operating Profit 12.31 9.95 10.31 -4.23 6.08 12.67 15.85 5.18 19.31 16.83 16.35 19.79 18.64
OPM % 27.03% 22.83% 25.58% -28.16% 20.04% 29.64% 30.65% 16.78% 33.18% 29.80% 29.37% 29.81% 27.11%
0.31 0.35 1.59 0.29 0.07 0.03 0.42 0.32 0.43 0.25 0.26 0.20 0.75
Interest 2.29 1.74 1.91 1.38 1.66 1.64 1.67 1.44 1.53 1.53 1.73 2.18 1.14
Depreciation 4.87 5.19 5.68 4.94 4.47 4.92 4.77 5.04 5.05 4.66 5.65 5.70 5.84
Profit before tax 5.46 3.37 4.31 -10.26 0.02 6.14 9.83 -0.98 13.16 10.89 9.23 12.11 12.41
Tax % 41.76% 27.60% 25.06% 25.83% 150.00% 27.85% 82.20% 25.51% 25.46% 25.16% 25.68% 24.77% 26.91%
Net Profit 3.19 2.44 3.23 -7.61 -0.01 4.43 1.75 -0.73 9.81 8.15 6.86 9.11 9.07
EPS in Rs 6.79 5.19 6.87 -16.19 -0.02 9.43 3.72 -1.55 20.87 17.34 14.60 19.38 19.30
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
103 104 109 113 118 137 149 153 170 176 140 201 247
90 92 96 102 103 119 126 129 140 129 109 143 176
Operating Profit 13 11 12 11 15 18 23 24 30 47 31 59 72
OPM % 12% 11% 11% 9% 13% 13% 15% 16% 18% 27% 22% 29% 29%
1 2 1 3 0 -5 1 2 2 3 1 1 1
Interest 4 5 4 4 4 5 4 3 4 9 7 7 7
Depreciation 6 6 5 6 6 9 9 10 11 21 19 20 22
Profit before tax 4 3 4 4 5 -0 11 13 17 20 6 32 45
Tax % 43% 45% 29% 35% -6% 104% 33% 49% 32% 31% 125% 25%
Net Profit 2 2 3 2 6 0 7 7 12 14 -1 24 33
EPS in Rs 4.56 3.56 6.98 5.17 12.13 0.09 15.62 14.43 25.36 29.11 -3.06 51.28 70.62
Dividend Payout % 26% 0% 17% 23% 10% 940% 10% 8% 6% 0% 0% 6%
Compounded Sales Growth
10 Years: 7%
5 Years: 6%
3 Years: 6%
TTM: 35%
Compounded Profit Growth
10 Years: 31%
5 Years: 26%
3 Years: 26%
TTM: 118%
Stock Price CAGR
10 Years: 30%
5 Years: 13%
3 Years: 65%
1 Year: 55%
Return on Equity
10 Years: 22%
5 Years: 22%
3 Years: 21%
Last Year: 36%

Balance Sheet

Figures in Rs. Crores

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
4 4 4 5 5 5 5 5 5 5 5 5 5
Reserves 7 9 11 14 19 19 25 30 41 51 50 73 90
30 29 28 28 27 31 23 18 24 60 68 193 200
15 16 19 20 18 24 20 28 31 24 33 42 45
Total Liabilities 56 57 63 67 69 79 72 81 100 141 155 314 340
25 23 23 26 26 34 33 36 55 94 96 214 226
CWIP 0 0 0 0 0 1 1 3 0 0 0 26 52
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
31 35 41 41 43 44 38 42 45 47 60 73 61
Total Assets 56 57 63 67 69 79 72 81 100 141 155 314 340

Cash Flows

Figures in Rs. Crores

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
11 11 11 12 14 17 20 19 25 39 34 57
-4 -4 -6 -11 -10 -17 -8 -11 -25 -17 -11 -46
-6 -7 -3 -3 -5 -0 -12 -8 2 -20 -8 -4
Net Cash Flow 1 1 2 -2 -1 0 0 -0 2 2 15 7

Ratios

Figures in Rs. Crores

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 25 18 13 19 19 24 16 17 19 14 23 16
Inventory Days 67 92 97 96 238 200 123 148 124 132 117 91
Days Payable 182 159 138 137 360 371 277 353 292 224 401 410
Cash Conversion Cycle -91 -49 -27 -22 -103 -146 -138 -189 -149 -78 -260 -302
Working Capital Days -21 -24 -32 -23 -5 -23 -18 -28 -11 -6 -20 -29
ROCE % 19% 18% 19% 17% 19% 18% 29% 32% 34% 30% 11% 20%

Shareholding Pattern

Numbers in percentages

Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
74.81 74.76 74.76 74.76 74.42 74.02 73.77 73.60 72.38 72.15 72.00 71.90
0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
25.18 25.24 25.24 25.24 25.58 25.98 26.23 26.40 27.62 27.85 28.00 28.09

* The XBRL reporting format changed from Sep'2022 onwards. The new format added details about banks and foreign portfolio investors. These were not available earlier.
The sudden increase in FII or DII might be because of these changes.

Please click on the line-items to see the names of individual entities.

Documents